0000950170-24-076262.txt : 20240621 0000950170-24-076262.hdr.sgml : 20240621 20240621162005 ACCESSION NUMBER: 0000950170-24-076262 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Richard A CENTRAL INDEX KEY: 0001490283 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40657 FILM NUMBER: 241060675 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Therapeutics, Inc. CENTRAL INDEX KEY: 0001850838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 949-4360 MAIL ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 ownership.xml 4 X0508 4 2024-06-20 0001850838 Omega Therapeutics, Inc. OMGA 0001490283 Young Richard A C/O OMEGA THERAPEUTICS, INC. 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 true false false false false Stock Option (Right to Buy) 2.20 2024-06-20 4 A false 25000 0.00 A 2034-06-19 Common Stock 25000 25000 D The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. /s/ Barbara Chan as Attorney-in-Fact for Richard A. Young, Ph.D. 2024-06-21